Ovarian Cancer Diagnostic Market Analysis
Report ID: GMI8316
|
Published Date: February 2024
|
Report Format: PDF
Download free sample
Get a free sample of Ovarian Cancer Diagnostic Market
Get a free sample of Ovarian Cancer Diagnostic Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,280 $5,350
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 14
Tables & Figures: 408
Countries covered: 22
Pages: 250
Download Free Sample
Ovarian Cancer Diagnostic Market Analysis
Download Free Sample
The market by product type is categorized into instruments/analyzers and consumables. The instruments/analyzers segment garnered USD 965.7 million revenue in 2023.
Download Free Sample
The ovarian cancer diagnostic market by diagnostic tests is categorized into imaging test, blood test, biopsy, and other diagnostic tests. The imaging test segment is further bifurcated into ultrasound, CT scan, MRI scan, PET scan, and other imaging tests. The imaging test segment garnered USD 625.4 million revenue in 2023.
Based on cancer type, the ovarian cancer diagnostic market is segmented into epithelial tumor, germ cell tumor, stromal cell tumor, and other cancer types. The epithelial tumor segment accounted for a revenue share of 90% in 2023 and is estimated to follow similar trend over the coming years.
The ovarian cancer diagnostic market by end-use is categorized into hospitals, diagnostic laboratories, diagnostic imaging centres, cancer research institutes, and other end-users. The hospitals segment accounted for around USD 396.4 million revenue size in 2023.
Download Free Sample
North America ovarian cancer diagnostic market accounted for USD 624.4 million revenue in 2023 and is predicted to witness substantial market growth.